Prevalence rates of many sexually transmitted infections (STIs) are highest among adolescents. If nonviral STIs are detected early, they can be treated, transmission to others can be eliminated, and sequelae can be averted. The US Preventive Services Task Force and the Centers for Disease Control and Prevention have published chlamydia, gonorrhea, and syphilis screening guidelines that recommend screening those at risk on the basis of epidemiologic and clinical outcomes data. This policy statement specifically focuses on these curable, nonviral STIs and reviews the evidence for nonviral STI screening in adolescents, communicates the value of screening, and outlines recommendations for routine nonviral STI screening of adolescents. Pediatrics 2014;134:e302-e311
EVIDENCE TO SUPPORT NONVIRAL STI SCREENINGThe goal of sexually transmitted infection (STI) screening is to identify and treat individuals with treatable infections, reduce transmission to others, avoid or minimize long-term consequences, identify other exposed and potentially infected individuals, and decrease the prevalence of infection in a community. Healthy People 2020 objectives for sexually transmitted diseases 1 include items that address screening for chlamydia in sexually active females younger than 25 years and set targets for decreased rates of chlamydia, gonorrhea, and syphilis in specific populations. The US Preventive Services Task Force (USPSTF), an independent panel of prevention and evidence-based medicine experts, has published chlamydia, 2 gonorrhea, 3 and syphilis 4,5 screening guidelines that recommend screening those at risk on the basis of epidemiologic and clinical outcomes data. The Centers for Disease Control and Prevention (CDC) publishes evidence-based STI screening recommendations for specific at-risk populations that are not addressed by the USPSTF but that pose public health challenges for disease prevention and control. 6-8 Major professional medical organizations, including the American College of Obstetricians and Gynecologists and the American Academy of Family Physicians, have also published STI screening guidelines for specific populations. 7-10 The American Academy of Pediatrics' (AAP) Bright Futures guidelines for health supervision recommend chlamydia and gonorrhea screening as appropriate for the patient population and the clinical setting. 11 Recent AAP clinical reports addressing gynecologic examinations and male reproductive and sexual health care discuss clinic issues and provider COMMITTEE ON ADOLESCENCE and SOCIETY FOR ADOLESCENT HEALTH AND MEDICINE